| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.9B | $6.0B | $32.7B | $34.2B | $35.4B | $32.2B | $32.1B | $32.8B |
| Cost of Revenue | $15.0B | $3.7B | $18.5B | $19.2B | $18.8B | $4.4B | $4.3B | $4.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | $0.7B | $1.0B | $1.1B | $1.2B | $1.1B | $1.3B | $1.3B |
| SG&A Expense | $4.0B | $4.2B | $21.5B | $9.0B | $7.2B | $6.9B | $7.0B | $7.6B |
| Operating Income | $4.6B | $4.8B | $-9.1B | $6.5B | $7.4B | $7.2B | $6.2B | $7.2B |
| Net Income | $3.3B | $0.7B | $-7.0B | $5.8B | $5.9B | $1.4B | $1.0B | $1.3B |
| EPS (Basic) | $6.05 | $1.34 | $-12.63 | $10.21 | $10.23 | $2.40 | $1.68 | $2.32 |
| EPS (Diluted) | $6.00 | $1.33 | $-12.63 | $10.18 | $10.12 | $2.38 | $1.66 | $2.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.7B | $39.9B | $50.6B | $46.5B | $47.1B | $47.3B | $44.7B | $36.5B |
| Current Assets | $16.4B | $15.9B | $16.4B | $14.7B | $15.4B | $15.0B | $13.0B | $13.7B |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $33.0B | $36.0B | $45.7B | $31.7B | $32.0B | $34.4B | $34.5B | $26.7B |
| Current Liabilities | $9.6B | $11.3B | $15.3B | $9.5B | $9.0B | $7.9B | $9.2B | $7.2B |
| Stockholders' Equity | $4.7B | $3.8B | $4.8B | $14.7B | $15.0B | $12.9B | $10.1B | $9.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B | $1.8B | $6.7B | $5.6B | $7.5B | $8.1B | $7.1B | $6.4B |
| Investing Cash Flow | $1.4B | $-3.2B | $-1.2B | $-1.0B | $-1.3B | $-0.6B | $-6.4B | $0.2B |
| Capital Expenditures | $0.9B | $1.2B | $1.6B | $1.7B | $1.6B | $1.5B | $1.7B | $1.6B |
| Financing Cash Flow | $-4.0B | $1.1B | $-3.1B | $-5.3B | $-6.1B | $-5.3B | $-1.1B | $-6.7B |